Ad Verification

Business

Marsh & McLennan: A Valuation Puzzle Amid Market Volatility

As Marsh & McLennan shares show mixed signals with a recent rebound but a sharp annual decline, investors are grappling with conflicting valuation metrics. While one model suggests a significant discount, traditional price-earnings analysis paints a different picture, highlighting the complexity of pricing the insurance brokerage giant in today's market.

Feb 5, 2026

Business

Evercore Posts Record Quarter, Boosts Shareholder Returns: Is the Rally Sustainable?

Investment bank Evercore capped a record year with strong Q4 results, announcing a dividend hike and completing a major share buyback. While the numbers underscore operational strength, analysts debate whether the stock's premium valuation adequately prices in cyclical risks.

Feb 5, 2026

Business

Delta Air Lines Bets Big on Long-Haul Growth with Major Airbus, Boeing Orders

Delta Air Lines has placed its largest widebody aircraft order in over a decade, securing new jets from both Airbus and Boeing to modernize its international fleet. The strategic move comes as the carrier navigates operational challenges from severe winter weather, signaling a long-term commitment to expanding its global reach.

Feb 5, 2026

Business

Fifth Third Bancorp's Rally Puts Valuation in Spotlight: Is the Stock Still a Buy?

Shares of Fifth Third Bancorp (FITB) have surged over 27% in the past year, outpacing many regional bank peers and drawing fresh scrutiny from investors. As the stock trades near $54, analysts are debating whether its current premium valuation is justified by fundamentals or signaling a potential pullback.

Feb 5, 2026

Business

Ultragenyx's Gene Therapy Milestone: A Turning Point for Sanfilippo Syndrome and the Biotech's Future?

New long-term data for Ultragenyx Pharmaceutical's UX111 gene therapy shows promise in halting cognitive decline in Sanfilippo syndrome type A, coinciding with a key FDA resubmission. While the development marks a significant scientific advance, it unfolds against a backdrop of persistent financial pressures for the company.

Feb 5, 2026

Business

Pfizer's Obesity Drug Candidate Shows Promise in Mid-Stage Trial, Bolstering Pipeline and Investor Outlook

Pfizer's once-monthly injectable obesity treatment, PF-3944, demonstrated significant weight loss in a Phase 2b study, positioning the pharmaceutical giant to challenge market leaders Novo Nordisk and Eli Lilly. The company plans an expansive Phase 3 program starting in 2026.

Feb 5, 2026

Business

Hershey Doubles Down on Easter with Expanded Candy Lineup, New Partnerships

The Hershey Company is significantly expanding its Easter confectionery offerings, introducing new products, flavors, and packaging formats across its major brands. The move, which includes a new partnership to bring AirHeads into the seasonal mix, underscores the critical importance of the Easter holiday to the chocolate giant's growth strategy and its push into broader snacking categories.

Feb 5, 2026

Business

Moelis & Co: A Value Trap or a Buying Opportunity Amidst Share Price Slump?

Moelis & Co's stock has faced significant headwinds over the past year, declining over 7%. While its long-term performance remains robust, recent weakness prompts a closer look at its valuation through multiple lenses—from excess returns to P/E ratios—to determine if the market has overcorrected.

Feb 5, 2026

Business

Coupang Data Breach Widens: 165,000 More South Korean Users Confirmed Affected

South Korean e-commerce giant Coupang has confirmed a significant expansion of last year's massive data breach, with personal information of an additional 165,000 users compromised. The revelation comes as the company remains under intense government scrutiny for the initial incident that impacted over 33 million customers.

Feb 5, 2026

Meta Doubles Down on Renewable Energy with Major Texas Solar Deal

Meta expands its clean energy portfolio through a new power purchase agreement with Zelestra for the Skull Creek Solar Plant in Texas, part of a broader 1.2GWdc partnership aiming for full operation by 2028.

Feb 5, 2026

Business

Atmos Energy Shareholders Greenlight Full Slate of Proposals, Backing Board and Executive Pay

Shareholders of Atmos Energy (NYSE: ATO) have delivered a strong vote of confidence, approving all eight proposals at the annual meeting. The sweeping approvals include the election of the full board, ratification of the auditor, and key governance amendments, signaling smooth sailing for the natural gas utility's leadership and strategic direction.

Feb 5, 2026

Business

Regional Management Caps 2025 with Strong Growth, Eyes Auto Loans and Expansion for 2026

Consumer finance provider Regional Management (NYSE: RM) reported robust fourth-quarter and full-year 2025 results, fueled by portfolio expansion and improved credit metrics. The company's leadership outlined an ambitious 2026 roadmap centered on branch network growth, a strategic push into auto-secured lending, and sustained tech investment.

Feb 5, 2026

Business

Prudential Faces $350M Hit from Japan Sales Scandal, Voluntarily Halts New Business for 90 Days

Prudential Financial's solid 2025 results were overshadowed by a misconduct scandal in its Japan unit, prompting a voluntary 90-day sales halt and a projected $300-$350 million earnings impact for 2026. CEO Andy Sullivan vowed to restore trust as the insurer navigates regulatory scrutiny and revamps its sales practices.

Feb 5, 2026

Business

Powering the AI Boom: Two Utility Giants Poised for Growth

As surging data center demand electrifies the traditionally steady utility sector, NextEra Energy and Dominion Energy emerge as key infrastructure players with compelling total return prospects.

Feb 5, 2026

Business

From Co-Founders to Courtroom Foes: Altman and Musk's AI Legal Showdown Heats Up

The bitter feud between OpenAI's Sam Altman and xAI's Elon Musk escalates as a multi-billion dollar fraud lawsuit heads to trial. With accusations of broken promises and evidence destruction, the April 2026 court date is set to be a defining moment for the future of AI governance and tech industry rivalries.

Feb 5, 2026

Business

CFTC Scraps Proposed Ban on Political and Sports Prediction Markets, Pledges New Regulatory Framework

In a major policy reversal, the U.S. Commodity Futures Trading Commission has formally withdrawn a contentious 2024 proposal that sought to outlaw event contracts tied to politics, sports, and conflict. Chairman Michael S. Selig dismissed the plan as a politically motivated overreach, signaling the agency's intent to regulate—not stifle—the fast-growing prediction market sector.

Feb 5, 2026

Business

Rural Wedding Venues Sound Alarm Over Labour's Tax Reforms

Industry leaders warn that soaring business rates and a lack of government support threaten the viability of countryside weddings, potentially pricing out couples and stifling a rural economic success story.

Feb 5, 2026

Business

Social Security's 2027 COLA Forecast: A Modest Rise That May Fall Short for Seniors

An early projection suggests a smaller cost-of-living adjustment for 2027, renewing concerns about benefits keeping pace with retirees' actual expenses.

Feb 5, 2026

World

UK Forges Alliance with Microsoft to Combat AI-Generated Deepfakes

The British government announces a collaborative initiative with Microsoft and leading experts to develop a national framework for detecting and assessing deepfake content, responding to a surge in AI-generated fraud and abuse.

Feb 5, 2026

Business

Moelis & Company Caps 2025 with Record Revenues, Eyes Active 2026 Deal Market

Buoyed by a surge in M&A and capital markets activity, investment bank Moelis & Company reported record quarterly and annual revenues for 2025. Executives point to a strengthened talent bench and improving operating leverage as catalysts for momentum heading into what they forecast will be a robust year for transactions.

Feb 5, 2026